Project Grant HT94252410213
Award Date
9/30/24
Completion Date
9/29/25
Dollars Obligated
$159K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
The University of Texas Southwestern Medical Center received a $2,458,810 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will support research from September 1, 2022 to August 31, 2025 to target neuroendocrine differentiation for nuclear imaging diagnosis and targeted radionuclide therapy of castration-resistant prostate cancer. The University of Texas System serves as the parent...
The University of Texas Southwestern Medical Center was awarded a $1,230,000 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research to cotarget the trinity of DNA damage repair sensing kinases in prostate cancer from September 30, 2021 to September 29, 2024. Through this funding, the Medical Center will investigate medical solutions for prostate cancer by exploring inhibition of the ataxia telangiectasia...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $324,452 Project Grant under the Military Medical Research and Development program (CFDA 12.420) by the Defense Health Agency. The grant, titled "Targeting PARP1 Trapping to Overcome PARP Inhibitor Resistance for BRCAmut Ovarian Cancers," will support research aimed at developing new treatments for ovarian cancer in military populations. The funding will enable UT Southwestern, a leading academic...
The University of Texas Southwestern Medical Center was awarded a $1,376,914 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on the "Modulation Effect of Folate on the Association Between Inorganic Arsenic and Aggressive Prostate Cancer." This 3-year grant, with a start date of September 1, 2023, will support basic, applied, and advanced biomedical research to investigate potential medical...
The University of Texas Southwestern Medical Center was awarded a $1,467,321 project grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund research from August 1, 2023 to July 31, 2026 to investigate the mechanisms controlling the progression of prostate adenocarcinoma to neuroendocrine cancer. As part of its mission to transform military and public health through innovative medical research solutions, the Defense Health Agency...
The University of Texas Southwestern Medical Center (UT Southwestern) was awarded a $319,798 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) on April 15, 2024. The grant supports UT Southwestern's research to dissect unconventional mechanisms of action and resistance to rapalogs, a class of drugs, in renal cell carcinoma. The research aims to make significant advances in military medicine by improving...
The University of Texas Southwestern Medical Center was awarded a $984,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Ribosome Marylation and Stress Responses in Ovarian Cancer: New Therapeutic Opportunities". The 3-year grant, effective September 1, 2024, will support basic science, translational, and clinical research to investigate new treatment approaches for ovarian cancer. As a...
The University of Texas Southwestern Medical Center will research NAD+ synthesis, mono(ADP-ribosylation), protein translation, and proteostasis in ovarian cancer under a $983,160 project grant from the Department of the Army Medical Command. The grant supports the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health through innovative biomedical research solutions for battlefield medicine. Through September 2024, the Medical...
This $1,124,825 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will support research at the University of Texas Health Science Center at San Antonio (UTHSCSA) to identify novel therapeutic targets for aggressive prostate cancer through induced pluripotent stem cell modeling of BRCA2 mutant prostate tissue. The award, which runs from August 1, 2024 to July 31, 2027, will enable UTHSCSA to conduct innovative...
This $1,189,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) aims to target stem-like CD8 T cells in immunotherapy against kidney cancer. The grant was awarded on September 1, 2023 to The University of Texas Southwestern Medical Center, an academic medical institution and component of the University of Texas System, to be completed by August 31, 2027. Through this funding, UT Southwestern will conduct research...